Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Olympus: Medical Systems Group Sales Up 9.3% to \127 Bil.
December 2, 2002
- Santen: Sales Up 6.1%, but Profits Down 41.6%
December 2, 2002
- Suzuken: Expansion of Pharmacy Market Drives Sales, Profits
December 2, 2002
- MEDICAL DEVICE NEWS IN BRIEF
December 2, 2002
- DIAGNOSTICS NEWS IN BRIEF
November 25, 2002
- Torii: Sales in 1st Half Down 7.9%
November 25, 2002
- New Drug Organization to Properly Conduct Safety Surveillance: Dr Sakaguchi
November 25, 2002
- Nippon Shinyaku: Sales, Profitability Show Signs of Recovery
November 25, 2002
- EAD Director Urges Wholesalers to Eliminate Inappropriate Trade Practices: FJPWA Seminar
November 25, 2002
- Ono: Mainstays Contribute to Sales, Profits Growth
November 25, 2002
- NEW PRODUCTS
November 25, 2002
- Dainippon: Sales Up, Profits Remain at Low Levels
November 25, 2002
- WEBSITE NEWS
November 25, 2002
- Tanabe Seiyaku: Record Profits Despite Lower Sales
November 25, 2002
- BUSINESS NEWS IN BRIEF
November 25, 2002
- Chugai: Net Loss Due to Merger-related Costs
November 25, 2002
- Abbott Japan to Be Formed on Feb. 2003
November 25, 2002
- Daiichi: Sales, Profits Down from Price Cut Impact on Mainstays
November 25, 2002
- Nippon Kayaku to Make Full Use of Own Unique Technology
November 25, 2002
- Shionogi: Contracting Market Hurts Semiannual Sales, Profits
November 25, 2002
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…